41
Participants
Start Date
September 8, 2021
Primary Completion Date
August 10, 2022
Study Completion Date
August 10, 2022
Treatment (CopaPrime+ (USANA Health Sciences)
Participants received and consumed 2 treatment tablets immediately following baseline testing, and one hour prior to post-treatment testing. Each tablet contained extracts of Bacopa monnieri (150 mg), Coffea arabica (50 mg), and Panax quinquefolius L. (50 mg)
Placebo
Participants received and consumed 2 placebo tablets immediately following baseline testing, and one hour prior to post-treatment testing. Each tablet contained microcrystalline cellulose. The size, shape and appearance of the placebo tablet was identical to the treatment tablet.
US Ski and Snowboard Center of Excellence, Park City
U.S. Ski & Snowboard
UNKNOWN
USANA Health Sciences
INDUSTRY